Literature DB >> 27965397

REM sleep behaviour disorder: prodromal and mechanistic insights for Parkinson's disease.

Anand Tekriwal1, Drew S Kern2, Jean Tsai2, Nuri F Ince3, Jianping Wu4, John A Thompson1, Aviva Abosch1.   

Abstract

Rapid eye movement (REM) sleep behaviour disorder (RBD) is characterised by complex motor enactment of dreams and is a potential prodromal marker of Parkinson's disease (PD). Of note, patients with PD observed during RBD episodes exhibit improved motor function, relative to baseline states during wake periods. Here, we review recent epidemiological and mechanistic findings supporting the prodromal value of RBD for PD, incorporating clinical and electrophysiological studies. Explanations for the improved motor function during RBD episodes are evaluated in light of recent publications. In addition, we present preliminary findings describing changes in the activity of the basal ganglia across the sleep-wake cycle that contribute to our understanding of RBD. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  EMG; MOTOR CONTROL; MULTISYSTEM ATROPHY; PARKINSON'S DISEASE; SLEEP DISORDERS

Mesh:

Year:  2016        PMID: 27965397     DOI: 10.1136/jnnp-2016-314471

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  9 in total

1.  Disrupted basal ganglia output during movement preparation in hemiparkinsonian mice is consistent with behavioral deficits.

Authors:  Anand Tekriwal; Mario J Lintz; John A Thompson; Gidon Felsen
Journal:  J Neurophysiol       Date:  2021-08-18       Impact factor: 2.974

2.  REM sleep behavior disorder and cerebrospinal fluid alpha-synuclein, amyloid beta, total tau and phosphorylated tau in Parkinson's disease: a cross-sectional and longitudinal study.

Authors:  Fardin Nabizadeh; Kasra Pirahesh; Parya Valizadeh
Journal:  J Neurol       Date:  2022-04-15       Impact factor: 6.682

3.  Different Perivascular Space Burdens in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson's Disease.

Authors:  Xiao-Li Si; Lu-Yan Gu; Zhe Song; Cheng Zhou; Yi Fang; Chong-Yao Jin; Jing-Jing Wu; Ting Gao; Tao Guo; Xiao-Jun Guan; Xiao-Jun Xu; Xin-Zhen Yin; Ya-Ping Yan; Min-Min Zhang; Jia-Li Pu
Journal:  Front Aging Neurosci       Date:  2020-11-05       Impact factor: 5.750

4.  Automatic Sleep Stage Classification Based on Subthalamic Local Field Potentials.

Authors:  Yue Chen; Chen Gong; Hongwei Hao; Yi Guo; Shujun Xu; Yuhuan Zhang; Guoping Yin; Xin Cao; Anchao Yang; Fangang Meng; Jingying Ye; Hesheng Liu; Jianguo Zhang; Yanan Sui; Luming Li
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2019-01-01       Impact factor: 3.802

5.  Clinical features of Parkinson's disease with and without rapid eye movement sleep behavior disorder.

Authors:  Ye Liu; Xiao-Ying Zhu; Xiao-Jin Zhang; Sheng-Han Kuo; William G Ondo; Yun-Cheng Wu
Journal:  Transl Neurodegener       Date:  2017-12-21       Impact factor: 8.014

6.  Heterogeneous digital biomarker integration out-performs patient self-reports in predicting Parkinson's disease.

Authors:  Kaiwen Deng; Yueming Li; Hanrui Zhang; Jian Wang; Roger L Albin; Yuanfang Guan
Journal:  Commun Biol       Date:  2022-01-17

Review 7.  Phosphatidylserine, inflammation, and central nervous system diseases.

Authors:  Xiaohua Ma; Xiaojing Li; Wenjuan Wang; Meng Zhang; Bo Yang; Zhigang Miao
Journal:  Front Aging Neurosci       Date:  2022-08-03       Impact factor: 5.702

8.  Efficacy of idebenone in the Treatment of iRBD into Synucleinopathies (EITRS): rationale, design, and methodology of a randomized, double-blind, multi-center clinical study.

Authors:  Yuanyuan Li; Chunyi Wang; Ningdi Luo; Fangzheng Chen; Liche Zhou; Mengyue Niu; Wenyan Kang; Jun Liu
Journal:  Front Neurol       Date:  2022-09-12       Impact factor: 4.086

9.  Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells.

Authors:  Amy M Smith; Constanze Depp; Brent J Ryan; Geoffrey I Johnston; Javier Alegre-Abarrategui; Samuel Evetts; Michal Rolinski; Fahd Baig; Claudio Ruffmann; Anna Katharina Simon; Michele T M Hu; Richard Wade-Martins
Journal:  Mov Disord       Date:  2018-10-07       Impact factor: 10.338

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.